Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis
Medical Mycology · 2023
DOI: 10.1093/mmy/myad063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Mycology, 2023. Verfasst von Priscila Marques de Macedo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Research on Infectious Dermatology, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de…. Hauptthemen laut MEDLINE: Sporotrichosis, Sporothrix. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: French National Research Agency, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.
Abstract (Originalsprache)
Sporotrichosis is an emergent public health problem. The mycological diagnosis of this infection is based on culture, which is fastidious and may represent a biohazard for technicians. Although not widely implemented in routine diagnosis, molecular methodologies are fast, have good accuracy, and can be easily standardized, aiding in the early diagnosis of neglected mycoses. This study aimed at implementing a new pan-Sporothrix quantitative reverse transcription PCR (RT-qPCR) assay, and then validating it on clinical samples from confirmed human sporotrichosis cases. A total of 68 human samples with culture-confirmed diagnosis of sporotrichosis were collected from 64 patients followed at a Brazilian reference center for endemic mycoses. These samples were submitted to whole nucleic acid extraction, followed by an RT-qPCR protocol. The limit of detection was 244 fg, the efficiency was 2.0 (100%), and the assay could amplify the genetic material of the three major clinically relevant species of the genus Sporothrix. Among the 68 samples analyzed, 62 were positive in RT-qPCR, showing an overall sensitivity of 91.18%, which variated according to the type of biological sample: 96.72% in skin samples (n = 61) and 100% in respiratory samples (n = 3), whereas all cerebrospinal fluid specimens (n = 4) were negative. The specificity was 100% when tested in 25 samples from patients with other mycoses and tuberculosis. In addition, DNA from 93 fungal species did not yield positive results, confirming the high specificity of this test. Our RT-qPCR presented high sensitivity and specificity, representing an excellent tool for a fast and reliable diagnosis of human sporotrichosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Research on Infectious Dermatology, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
- Laboratory of Parasitology-Mycology, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Translational Mycology Group, National Reference Center for Invasive Mycoses and Antifungals, Institut Pasteur, Paris, France.
- Mycology Laboratory, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
- Department of Microbiology, Immunology and Parasitology, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
ORCID-Profile: Priscila Marques de Macedo, Rodrigo Almeida-Paes, Alexandre Alanio
Förderung
- French National Research Agency
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- São Paulo Research Foundation
- CNPq
Zitieren
APA
Marques de Macedo, P., Sturny-Leclère, A., Freitas, D. F. S., Ghelfenstein-Ferreira, T., Gutierrez-Galhardo, M. C., Almeida, M. A., Rodrigues, A. M., Pautet, T., Hamane, S., Almeida-Paes, R., Zancopé-Oliveira, R. M., & Alanio, A. (2023). Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis. Medical Mycology. https://doi.org/10.1093/mmy/myad063
Vancouver
Marques de Macedo P, Sturny-Leclère A, Freitas DFS, Ghelfenstein-Ferreira T, Gutierrez-Galhardo MC, Almeida MA, et al. Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis. Medical Mycology. 2023. doi:10.1093/mmy/myad063
BibTeX
@article{MarquesdeMacedo2023,
author = {Marques de Macedo, Priscila and Sturny-Leclère, Aude and Freitas, Dayvison Francis Saraiva and Ghelfenstein-Ferreira, Theo and Gutierrez-Galhardo, Maria Clara and Almeida, Marcos de Abreu and Rodrigues, Anderson Messias and Pautet, Thierry and Hamane, Samia and Almeida-Paes, Rodrigo and Zancopé-Oliveira, Rosely Maria and Alanio, Alexandre},
title = {Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis},
journal = {Medical Mycology},
year = {2023},
doi = {10.1093/mmy/myad063}
}
EUVIMED